Atlas Trials

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Clinical trial NCT06540261 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06540261
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Unresectable Colorectal Cancer
Start date
2021-09-23
Primary completion
2027-12-31
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.